Nexalis Therapeutics Limited has released a press release.
Amended - Appendix 4C September 2018 Quarter
Filed with ASX ·
6ix hasn’t read this filing yet.
Nexalis Therapeutics Limited on 6ix
Story so far
Earlier from Nexalis Therapeutics
- Commercial Sales and Distribution Agreement with CBDS Health
- First production completed for strong vape segment growth
- LSH Acquires Seng Vital for Cannabis Opportunities
- Lifespot Strengthens Go-To-Market Cannabis Strategy
- Update on Unique Cannabis Vaporiser launch and Bodytel
Later from Nexalis Therapeutics
- Business Development focus in rapid growth Cannabis Category
- Lifespot signs heads of agreement with ionic brands
- Production of new slim line smart vaporiser for usa
- Private Placement Successfully Completed to raise $330,000
- Pause in trading
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics